Company Harpoon Therapeutics, Inc.
Equities
HARP
US41358P2056
Biotechnology & Medical Research
Business Summary
Number of employees: 53
Managers
Managers | Title | Age | Since |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/18/11 |
Frank Lanza
DFI | Director of Finance/CFO | 62 | 01/19/01 |
Chatan Charan
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Holger Wesche
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/18/01 |
Luke Walker
CTO | Chief Tech/Sci/R&D Officer | - | 03/22/03 |
Haibo Wang
PRN | Corporate Officer/Principal | - | 01/23/01 |
Banmeet Anand
PRN | Corporate Officer/Principal | - | 06/22/06 |
Wendy Chang
HRO | Human Resources Officer | - | 06/22/06 |
Rachael Lester
PRN | Corporate Officer/Principal | - | 01/17/01 |
James B. Bucher
LAW | General Counsel | 59 | 26/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Julia Eastland
CEO | Chief Executive Officer | 59 | 11/18/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,397,205 | 16,465,638 ( 76.95 %) | 0 | 76.95 % |
Company contact information
Harpoon Therapeutics, Inc.
611 Gateway Boulevard Suite 400
94080, South San Francisco
+650 443 7400
http://www.harpoontx.comSector
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.79% | 22.15B | |
-17.37% | 21.02B | |
-8.05% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |